rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-2-28
|
pubmed:abstractText |
This study was the first clinical trial in Taiwan of a new thrombolytic agent human tissue urokinase type plasminogen activator (HTUPA) in patients with acute ischemic stroke.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1524-4628
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
918-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16424373-Aged,
pubmed-meshheading:16424373-Brain Ischemia,
pubmed-meshheading:16424373-Cerebral Hemorrhage,
pubmed-meshheading:16424373-Female,
pubmed-meshheading:16424373-Fibrinolytic Agents,
pubmed-meshheading:16424373-Humans,
pubmed-meshheading:16424373-Incidence,
pubmed-meshheading:16424373-Male,
pubmed-meshheading:16424373-Middle Aged,
pubmed-meshheading:16424373-Pilot Projects,
pubmed-meshheading:16424373-Severity of Illness Index,
pubmed-meshheading:16424373-Stroke,
pubmed-meshheading:16424373-Taiwan,
pubmed-meshheading:16424373-Thrombolytic Therapy,
pubmed-meshheading:16424373-Time Factors,
pubmed-meshheading:16424373-Tissue Plasminogen Activator,
pubmed-meshheading:16424373-Treatment Outcome,
pubmed-meshheading:16424373-Urokinase-Type Plasminogen Activator
|
pubmed:year |
2006
|
pubmed:articleTitle |
A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window.
|
pubmed:affiliation |
Department of Neurology, Taipei Veterans General Hospital, Taiwan. hhhu@vghtpe.gov.tw
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|